Tender for a Surface Plasmon Resonance (SPR) Instrument

A Contract Award Notice
by SWANSEA UNIVERSITY

Source
OJEU
Type
Contract (Supply)
Duration
1 year (est.)
Value
£221K
Sector
INDUSTRIAL
Published
31 Aug 2021
Delivery
To 31 Aug 2022 (est.)
Deadline
n/a

Concepts

Location

Swansea University Medical School

Geochart for 2 buyers and 1 suppliers

2 buyers

1 supplier

Description

For antibody development, the SPR detection instrument will be used for early-stage screening of hybridoma/bispecific libraries, to monitor expression and triage antibodies based on binding affinity, profiling binding specificity and providing detailed binding kinetics and affinity to characterisation.

Total Quantity or Scope

The Cluster for Epigenomics and Antibody drug conjugate (ADC) Therapeutics (CEAT) is a GBP 2.6m project, led by the Reproductive Biology and Gynaecological Oncology (RBGO) group at Swansea University Medical School and is looking to develop advanced drug technologies for the treatment of ovarian cancer.

Award Detail

1 Global Life Sciences Solutions Operations (Amersham)
  • Reference: su56(21)
  • Num offers: 2
  • Value: £221,000
  • Contractor is an SME.

Award Criteria

Technical & Software Requirements 50.0
After Sales Support & Warranty 15.0
Lead Time 15.0
PRICE 20.0

CPV Codes

  • 38000000 - Laboratory, optical and precision equipments (excl. glasses)

Indicators

  • Award on basis of price and quality.

Other Information

(WA Ref:113557)

Reference

Domains